https://www.selleckchem.com/pr....oducts/jnj-64619178.
009) area under the curve (AUC). The BICARB session had lower acylated ghrelin at 60 (P=0.014) and 90 min post-exercise (P=0.016) with a decreased AUC (P=0.039). The BICARB session had increased PYY (P=0.034) with an increased AUC (P=0.031). The BICARB session also tended (P=0.06 to have increased GLP-1 at 30 (P=0.003) and 60 min post-exercise (P less then 0.001) with an increased AUC (P=0.03. The BICARB session tended (P=0.059) to reduce overall appetite, though there was no difference in AUC (P=0.149). These findings support